Biotricity Inc. Forms Scientific and Medical Alliance Board
November 06, 2018 at 08:00 am EST
Share
Biotricity Inc. announced that Drs. Donald S. (Buck) Cross, Edward Lazaga, Imran Mohiuddin, Radoslaw (Stefan) Kiesz, and Tea Acuff will be joining the Company’s Scientific and Medical Alliance Board. The new alliance members will apply their expertise to support the research and development process at Biotricity with a focus on scientific and clinical excellence. Dr. Buck Cross specializes in complex and high-risk interventions and treatment of chronic total coronary occlusions and peripheral vascular disease. He is the National Medical Director for National Cardiovascular Partners, and a Fellow at the American College of Cardiology. Dr. Edward Lazaga specializes in Internal Medicine and has over 33 years of experience. He focuses on the diagnosis and treatment of both acute and chronic conditions. Dr. Lazaga is affiliated with multiple hospitals in Texas, including the Baptist Medical Center and Christus Santa Rosa Health System-San Antonio. Dr. Imran Mohiuddin specializes in vascular surgery and has been practicing for 21 years. He received his board certification in Vascular Surgery from the Baylor College of Medicine. Dr. Stefan Kiesz specializes in interventional cardiology and endovascular surgery. He is the Co-founder and deputy Chairman of the Supervisory Board of American Heart of Poland, and the Clinical Professor of Medicine and Cardiology at the University of Texas. Dr. Tea Acuff specializes in Cardiovascular and Thoracic Surgery. He is Chairman of the Cardiovascular Division at the Denton Regional Medical Center and a member of the Texas Medical Association and the Dallas County Medical Association.
Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patientâs electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.